Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urethral Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Prostatic Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Gemcitabine 9Paclitaxel 7Carboplatin 5Cisplatin 4Vinblastine 3Methotrexate 3Doxorubicin 2rubitecan 1romidepsin 1piritrexim 1lonafarnib 1Surgical Procedures, Operative 1Radiotherapy 1Pemetrexed 1Neoadjuvant Therapy 1Irinotecan 1Gefitinib 1Docetaxel 1Depsipeptides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Urethral Neoplasms × Gefitinib × Clear all
NCT00014144 2012-10-08

S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

SWOG Cancer Research Network

Phase 2 Completed
31 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡